Home
About Us
About the Bing Center
Directions / Find Us
Staff
Amanda Kofides, BS
Zachary Hunter, Ph.D
Steven Treon, MD, Ph.D
Phil Brodsky, BS
Nick Tsakmaklis, BA
Kirsten Meid, BA, MPH
Jorge Castillo, MD
Christopher Patterson, MS, BASc
Shayna Sarosiek, MD
Margaret Kobs DNP, FNP-BC
Hannah Chory, FNP-BC
Nina Budano, CRC II
Julia Nguyen, CRC
Alexandra Eurell, RC II
Alberto Guijosa Ramirez, MD
Maria Luisa Guerrera, MD
Tarek Mouhieddine, MD
Camille V. Edwards, MBBS
About WM
WM Overview
About WM
How We Diagnose WM
How We Treat WM
Patients
WM Clinic
Clinical Trials
News
Bing Center News
Newsletter Archive
Spotlight
Resources
Related Web Links
Media Gallery
Donate
Learn More
YouTube
Pubs
Contact
Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenstrom Macroglobulinemia.
If the document is not displayed
Click Here to view the document
Previous article: Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenstrom Macroglobulinemia
Prev
Next article: Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.
Next
